Megna Michael R — SEC insider filings
SEC reporting owner CIK 1464583. 40 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-09-14 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 14 filings — 228,581 shares, $10,232,568 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 182.
- Largest priced transaction: sale of 37,255 shares @ $38.72 ($1,442,514) in Kiniksa Pharmaceuticals International, plc, filed 2025-10-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | 40 | — | 23 legs · 228,581 sh · $10,232,568 | 182 |
Insider filings — Megna Michael R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 11,280 @ $17.76 · Sale (S): 11,280 @ $98.54 · Option exercise (M): 11,280 (derivative) @ $0 | EDGAR |
| 2026-11-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 4,689 @ $10.76 · Option exercise (M): 3,932 @ $11.10 · Option exercise (M): 7,209 @ $11.97 · Option exercise (M): 4,065 @ $17.76 · Sale (S): 6,030 @ $91.87 · Sale (S): 6,831 @ $92.77 · +9 more | EDGAR |
| 2026-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 279 @ $33.50 · Option exercise (M): 3,932 · Option exercise (M): 2,558 · Option exercise (M): 2,362 · Option exercise (M): 2,644 · Tax withholding (F): 5,531 @ $79.28 · +7 more | EDGAR |
| 2026-04-13 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale (S): 6,625 @ $46.69 | EDGAR |
| 2026-04-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,932 @ $1 · Tax withholding (F): 1,666 @ $48.94 · Option exercise (M): 3,932 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 372 @ $24.16 · Option exercise (M): 7,564 · Tax withholding (F): 3,205 @ $48.13 · Grant/award (A): 14,600 (derivative) @ $0 · Grant/award (A): 3,650 (derivative) @ $0 · Grant/award (A): 7,300 (derivative) @ $0 · +3 more | EDGAR |
| 2025-10-22 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 791 @ $15.50 · Option exercise (M): 6,195 @ $12.97 · Option exercise (M): 9,831 @ $11.10 · Option exercise (M): 9,831 @ $11.97 · Option exercise (M): 12,787 @ $10.76 · Sale (S): 37,255 @ $38.72 · +6 more | EDGAR |
| 2025-10-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 175 · Tax withholding (F): 85 @ $38.49 · Option exercise (M): 175 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,363 · Option exercise (M): 2,557 · Option exercise (M): 3,933 · Tax withholding (F): 4,282 @ $33.49 · Option exercise (M): 774 · Tax withholding (F): 375 @ $34.28 · +9 more | EDGAR |
| 2025-08-06 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 495 @ $15.63 · Option exercise (M): 17,000 @ $15.52 · Sale (S): 17,000 @ $32.35 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 15,211 @ $15.50 · Sale (S): 15,211 @ $28.75 · Option exercise (M): 15,211 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 229 @ $8.83 · Option exercise (M): 2,998 @ $15.50 · Option exercise (M): 14,420 @ $11.97 · Sale (S): 17,647 @ $26.69 · Option exercise (M): 229 (derivative) @ $0 · Option exercise (M): 2,998 (derivative) @ $0 · +1 more | EDGAR |
| 2025-05-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 3,270 (derivative) @ $0 · Grant/award (A): 3,433 (derivative) @ $0 · Grant/award (A): 5,285 (derivative) @ $0 · Grant/award (A): 5,456 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,933 · Tax withholding (F): 1,666 @ $20.28 · Option exercise (M): 3,933 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,557 · Option exercise (M): 2,363 · Tax withholding (F): 1,083 @ $21.77 · Tax withholding (F): 1,001 @ $21.77 · Grant/award (A): 21,150 (derivative) @ $0 · Grant/award (A): 10,575 (derivative) @ $0 · +2 more | EDGAR |
| 2025-03-19 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 469 @ $16 · Option exercise (M): 774 · Tax withholding (F): 328 @ $22.61 · Option exercise (M): 774 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 9,051 @ $11.10 · Sale (S): 9,051 @ $22.45 · Option exercise (M): 9,051 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 8,637 @ $11.10 · Sale (S): 8,637 @ $22.45 · Option exercise (M): 9 @ $11.10 · Sale (S): 9 @ $22.45 · Option exercise (M): 8,637 (derivative) @ $0 · Option exercise (M): 9 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 175 · Tax withholding (F): 82 @ $24.48 · Option exercise (M): 175 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 480 @ $15.65 · Option exercise (M): 6,490 · Tax withholding (F): 2,755 @ $26.74 · Option exercise (M): 775 · Tax withholding (F): 329 @ $26.74 · Grant/award (A): 9,450 (derivative) @ $0 · +4 more | EDGAR |
| 2024-04-08 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 3,932 · Tax withholding (F): 1,666 @ $17.90 · Grant/award (A): 18,900 (derivative) @ $0 · Grant/award (A): 9,450 (derivative) @ $0 · Option exercise (M): 3,932 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,558 · Tax withholding (F): 1,084 @ $19.70 · Option exercise (M): 2,558 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 583 @ $12.35 · Option exercise (M): 5,126 @ $8.83 · Sale (S): 5,126 @ $21.79 · Option exercise (M): 5,645 @ $8.83 · Option exercise (M): 4,014 @ $13.88 · Sale (S): 9,659 @ $21.45 · +3 more | EDGAR |
| 2024-01-04 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 16,670 @ $13.88 · Sale (S): 16,670 @ $19.17 · Option exercise (M): 16,670 (derivative) @ $0 | EDGAR |
| 2023-12-21 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 9,316 @ $13.88 · Sale (S): 9,316 @ $19.13 · Option exercise (M): 9,316 (derivative) @ $0 | EDGAR |
| 2023-10-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 175 · Tax withholding (F): 52 @ $16.01 · Option exercise (M): 175 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 581 @ $12.35 · Option exercise (M): 3,933 · Tax withholding (F): 1,155 @ $17.76 · Option exercise (M): 774 · Tax withholding (F): 228 @ $17.76 · Option exercise (M): 3,933 (derivative) @ $0 · +3 more | EDGAR |
| 2023-04-11 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 3,933 · Tax withholding (F): 1,155 @ $10.71 · Option exercise (M): 3,933 (derivative) @ $0 | EDGAR |
| 2023-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 20,459 (derivative) @ $0 · Grant/award (A): 10,230 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 704 @ $9.56 · Option exercise (M): 774 · Tax withholding (F): 221 @ $11.46 · Option exercise (M): 2,163 · Tax withholding (F): 635 @ $11.12 · Option exercise (M): 774 (derivative) @ $0 · +1 more | EDGAR |
| 2022-10-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 175 · Tax withholding (F): 52 @ $14.23 · Option exercise (M): 175 (derivative) @ $0 | EDGAR |
| 2022-09-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 703 @ $9.56 · Option exercise (M): 775 · Tax withholding (F): 228 @ $11.44 · Grant/award (A): 31,460 (derivative) @ $0 · Grant/award (A): 15,730 (derivative) @ $0 · Option exercise (M): 775 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 31,460 (derivative) @ $0 · Grant/award (A): 15,730 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 3,231 · Tax withholding (F): 1,120 @ $10.98 · Option exercise (M): 3,231 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 641 @ $9.51 · Grant/award (A): 405 @ $15.02 · Grant/award (A): 588 @ $11.49 · Grant/award (A): 653 @ $9.63 · Option exercise (M): 775 · Tax withholding (F): 269 @ $10.13 · +1 more | EDGAR |
| 2021-10-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 700 (derivative) @ $0 | EDGAR |
| 2021-09-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 6,195 (derivative) @ $0 · Grant/award (A): 3,098 (derivative) @ $0 | EDGAR |
| 2021-03-23 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 3,231 (derivative) @ $0 · Grant/award (A): 2,163 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 6,195 (derivative) @ $0 · Grant/award (A): 3,098 (derivative) @ $0 | EDGAR |
| 2020-09-14 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1464583 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs